Research Article Details

Article ID: A19625
PMID: 26449539
Source: BMC Genomics
Title: The impact of PPARα activation on whole genome gene expression in human precision cut liver slices.
Abstract: BACKGROUND: Studies in mice have shown that PPAR&#945; is an important regulator of lipid metabolism in liver and key transcription factor involved in the adaptive response to fasting. However, much less is known about the role of PPAR&#945; in human liver. METHODS: Here we set out to study the function of PPAR&#945; in human liver via analysis of whole genome gene regulation in human liver slices treated with the PPAR&#945; agonist Wy14643. RESULTS: Quantitative PCR indicated that PPAR&#945; is well expressed in human liver and human liver slices and that the classical PPAR&#945; targets PLIN2, VLDLR, ANGPTL4, CPT1A and PDK4 are robustly induced by PPAR&#945; activation. Transcriptomics analysis indicated that 617 genes were upregulated and 665 genes were downregulated by PPAR&#945; activation (q value&#8201;<&#8201;0.05). Many genes induced by PPAR&#945; activation were involved in lipid metabolism (ACSL5, AGPAT9, FADS1, SLC27A4), xenobiotic metabolism (POR, ABCC2, CYP3A5) or the unfolded protein response, whereas most of the downregulated genes were involved in immune-related pathways. Among the most highly repressed genes upon PPAR&#945; activation were several chemokines (e.g. CXCL9-11, CCL8, CX3CL1, CXCL6), interferon &#947;-induced genes (e.g. IFITM1, IFIT1, IFIT2, IFIT3) and numerous other immune-related genes (e.g. TLR3, NOS2, and LCN2). Comparative analysis of gene regulation by Wy14643 between human liver slices and primary human hepatocytes showed that down-regulation of gene expression by PPAR&#945; is much better captured by liver slices as compared to primary hepatocytes. In particular, PPAR&#945; activation markedly suppressed immunity/inflammation-related genes in human liver slices but not in primary hepatocytes. Finally, several putative new target genes of PPAR&#945; were identified that were commonly induced by PPAR&#945; activation in the two human liver model systems, including TSKU, RHOF, CA12 and VSIG10L. CONCLUSION: Our paper demonstrates the suitability and superiority of human liver slices over primary hepatocytes for studying the functional role of PPAR&#945; in human liver. Our data underscore the major role of PPAR&#945; in regulation of hepatic lipid and xenobiotic metabolism in human liver and reveal a marked immuno-suppressive/anti-inflammatory effect of PPAR&#945; in human liver slices that may be therapeutically relevant for non-alcoholic fatty liver disease.
DOI: 10.1186/s12864-015-1969-3